Due Diligence and Art

Due Diligence and Art

mRNA, Gene Therapies and Biomanufacturing Fraud

Mainstream pharma press admits that CRISPR technology failed.

Moments of honesty from the least expected places should be cherished.

Sasha Latypova's avatar
Sasha Latypova
Mar 28, 2025
∙ Paid

If you stand on a river bank and wait for failed gene therapies to float by… you will be flooded! Admission of failure from the pharma propaganda outlets, on the other hand, is a rare event. This washed up in my inbox recently:

“Exclusive: CRISPR delivery startup, based on UC Berkeley and UCSF science, shuts down.”

Due Diligence and Art is a reader-supp…

User's avatar

Continue reading this post for free, courtesy of Sasha Latypova.

Or purchase a paid subscription.
© 2026 Sasha Latypova · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture